The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
Index/Startups & Founders/Running Through Walls
Running Through Walls artwork

The Long Game of Building Breakthrough Biotech

Running Through Walls · 2026-06-02 · 26 min

0:00--:--

Episode notes

Nimish Shah sits down with Andy Robbins, CEO of Cogent Biosciences, for a candid conversation about building a targeted therapy company in oncology. Andy shares how Cogent made high-stakes decisions around bezuclastinib, why speed matters in biotech, and what it takes to build conviction years before clinical answers arrive. They also dig into what's overhyped, what's undervalued, and why the best biotech leaders stay humble, fast-moving, and relentlessly focused on patients.

More from Running Through Walls

All episodes →
  • Healthcare Prognosis 202672 / 100
  • Arca's AI-First Vision for Human-First Wealth Management
  • Building a Differentiated Obesity Biotech
  • SmithRx's Mission to Break the Drug Pricing Black Box
  • Pursuit over Podium: Rethinking Excellence with Brad Stulberg
Explore the best B2B Startups & Founders podcasts →
All Running Through Walls episodes →